Mutations or dysregulation of CHMP4B have been associated with various diseases, including neurodegenerative disorders like frontotemporal dementia (FTD) and Alzheimer's disease (AD) 69, 70. This evidence concerns the gene CHMP4B and Alzheimer disease.